- Видео 162
- Просмотров 11 399
International CML Foundation
Великобритания
Добавлен 26 фев 2023
The International CML Foundation (iCMLf) is on a mission to improve outcomes for patients with CML, globally.
Founded by a dedicated group of hematologists, we are committed to ensuring every patient with CML, no matter where they are in the world, receives the best possible care. We foster international collaboration to elevate knowledge, enhance diagnostics, and drive ground-breaking research.
As a charitable foundation with a global reach, we strive to empower physicians, researchers, patients and caregivers alike, in the collective pursuit of a cure.
Join us and contribute to a world where a cure for CML is not just a hope, but a reality.
Founded by a dedicated group of hematologists, we are committed to ensuring every patient with CML, no matter where they are in the world, receives the best possible care. We foster international collaboration to elevate knowledge, enhance diagnostics, and drive ground-breaking research.
As a charitable foundation with a global reach, we strive to empower physicians, researchers, patients and caregivers alike, in the collective pursuit of a cure.
Join us and contribute to a world where a cure for CML is not just a hope, but a reality.
Secuenciación del tratamiento con TKI y manejo de los efectos crónicos del tratamiento con TKI
To view this video in the original English, click here: ruclips.net/video/4056-8mUETg/видео.html
Para ver este vídeo con traducción al portugués, haga clic aquí: ruclips.net/video/OTbslHmIuvs/видео.html
Expertas regionales:
Dr Lilian Pilleux
Universidad Austral de Chile
and Valdivia Hospital
Valdivia, Chile
Dr Katia Pagnano
Centro de Hematologia e Hemoterapia (HEMOCENTRO)
Universidade Estadual de Campinas (UNICAMP),
Brasil
Expertos internacionales:
Associate Professor David Yeung
South Australian Health and Medical Research Institute,
Adelaide, Australia
Dr Jeff Lipton
University of Toronto and
Princess Margaret Cancer Centre,
Toronto, Canada
00:00 Bienvenida e introducción
02:47 Elección y secuenciación del...
Para ver este vídeo con traducción al portugués, haga clic aquí: ruclips.net/video/OTbslHmIuvs/видео.html
Expertas regionales:
Dr Lilian Pilleux
Universidad Austral de Chile
and Valdivia Hospital
Valdivia, Chile
Dr Katia Pagnano
Centro de Hematologia e Hemoterapia (HEMOCENTRO)
Universidade Estadual de Campinas (UNICAMP),
Brasil
Expertos internacionales:
Associate Professor David Yeung
South Australian Health and Medical Research Institute,
Adelaide, Australia
Dr Jeff Lipton
University of Toronto and
Princess Margaret Cancer Centre,
Toronto, Canada
00:00 Bienvenida e introducción
02:47 Elección y secuenciación del...
Просмотров: 175
Видео
Regional Discussion Group July 2024 - Latin America - TKI Sequencing and Managing Chronic Effects
Просмотров 4614 дней назад
TKI Sequencing of Treatment, and Managing Chronic Effects of TKI Treatment Para ver este video con traducción al español, haga clic aquí: ruclips.net/video/-2Zgt_kKnzQ/видео.html Para ver este vídeo con traducción al portugués, haga clic aquí: ruclips.net/video/OTbslHmIuvs/видео.html Regional Experts: Dr Lilian Pilleux Universidad Austral de Chile and Valdivia Hospital Valdivia, Chile Dr Katia ...
CML Highlights of EHA 2024 - Biological overview
Просмотров 134Месяц назад
Professor Nick Cross Professor of Human Genetics at the University of Southampton Southampton (UK) 00:00 Introduction Prediction of DMR/TFR 01:17 Abstract S167: A novel immune-related score predicts deep molecular response in chronic-phase CML treated upfront with TKIs 03:19 Abstract S166: A machine-learning approach identifies a 27-genes transcriptome signature predicting TFR in CML 05:32 Abst...
CML Highlights of EHA 2024 - Clinical overview
Просмотров 142Месяц назад
Professor Andreas Hochhaus Director of the Department of Hematology and Medical Oncology Jena University Hospital (Germany) 00:00 Welcome and introduction 02:01 Treatment optimisation in CML (Hochhaus EHA 2024) 03:25 Line-agnostic treatment recommendations according to clinical and biological data 04:38 Asciminib first-line ASC4 First (Hochhaus et al, EHA 2024) 09:21 Dasatinib dose optimisation...
Regional Discussion Group - June 24 - Latin America: TFR vs Dose Reduction
Просмотров 62Месяц назад
In the first of our Latin America Regional Discussion Groups for 2024 we debate whether TFR or dose reduction is the better pathway to stopping therapy. Experts: Dr Virginia Abello Polo Center for Cancer Treatment and Research Luis Carlos Sarmiento Angulo Foundation, Bogota, Colombia Professor Ehab Atallah Hematologic Malignancies Division of Hematology & Oncology, Medical College of Wisconsin,...
Regional Discussion Group June 24 South Asia 3 of 3 - When & How to Set Up High Quality Testing Labs
Просмотров 492 месяца назад
iCMLf Regional Discussion Group 26 June 2024: South Asia 2023 ELN laboratory recommendations - Challenges in low- and middle-income countries When and How to Set Up High-Quality Testing Laboratories when Resources are Limited Part 3 of 3 Presenter: Professor Deepak Kumar Mishra TATA Medical Center, Kolkata, India Regional Experts: Dr Zeeshan Ansar Ahmed The Aga Khan University Karachi, Pakistan...
Regional Discussion Group June 24 South Asia 2 of 3 - When and How to look for BCR::ABL1 Mutations
Просмотров 382 месяца назад
iCMLf Regional Discussion Group 26 June 2024: South Asia 2023 ELN laboratory recommendations - Challenges in low- and middle-income countries When and How to look for BCR::ABL1 Mutations Part 2 of 3 Presenter: Dr Zeeshan Ansar Ahmed The Aga Khan University Karachi, Pakistan Regional Experts: Dr Mohammad Ali National Institute of Cancer Research and Hospital Mohakhali, Dhaka, Bangladesh Professo...
Regional Discussion Group June 24 South Asia 1 of 3 - BCR::ABL1 Testing
Просмотров 362 месяца назад
iCMLf Regional Discussion Group 26 June 2024: South Asia 2023 ELN laboratory recommendations - Challenges in low- and middle-income countries BCR::ABL1 Testing - When and How to Test When Resources are Limited Part 1 of 3 Presenter: Dr Mohammad Ali National Institute of Cancer Research and Hospital Mohakhali, Dhaka, Bangladesh Regional Experts: Dr Zeeshan Ansar Ahmed The Aga Khan University Kar...
Regional Discussion Group 29 May 2024 South Asia 2 of 2 - The Role of Allogenic Stem Cell Transplant
Просмотров 483 месяца назад
Experts: Professor Sadashivudu Gundeti Nizam's Institute of Medical Sciences Hyderabad, India Professor Naeem Chaudhri King Faisal Specalist Hospital and Research Centre Riyadh, Saudi Arabia 00:00 Introduction 00:44 Case 1: Difficulty finding matched donor and resource constraints 04:51 Discussion of Case 1 17:22 Case 2: Transplant for a drug-resistant mutation 22:37 Discussion of case 2 33:22 ...
Regional Discussion Group 29 May 2024 South Asia 1 of 2 - The Realities of Long-Term Treatment
Просмотров 823 месяца назад
Experts Professor Mehreen Ali Khan Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan Professor Mike Mauro Memorial Sloan Kettering Cancer Centre New York City, USA 00:00 Welcome 02:37 Introduction 05:31 Case 1: A Case of TKI-Resistant CML, post Allo-BMT and TKI-induced complications 17:21 Discussion of Case 1 32:32 Case 2: Patient on Nilotinib develops hyperbilirubinemia 38:27 Di...
Annapurna 2023: What the iCMLf Did Next…
Просмотров 493 месяца назад
After six months, as we reflect on the journey we embarked on together last November during the iCMLf Climb for a Cure: Annapurna, we're still filled with gratitude for your unwavering support and donations of over $200,000! Since the Annapurna 2023 challenge, the iCMLf has continued to make significant strides in several key areas. Watch to more about the climb and what we've been up to since!...
South Asian Regional Discussion Group April 24, 2024
Просмотров 1443 месяца назад
00:00 Welcome and Introduction: Topic 1 - TKI choice and sequencing of treatment in a world of increasing options 03:13 Case 1: Challenges: Choice of first line therapy - what to look for in your first TKI 08:41 Expert discussion of Case 1 19:03 Case 2: Challenges: If no mutation, how to choose second line? 24:08 Expert discussion of Case 2 34:25 General Discussion and questions from the audien...
Ride for a Cure
Просмотров 1783 месяца назад
Support Team Incyte as they cycle 710km and Ride for a Cure through the French Alps, raising money for the International CML Foundation (iCMLf). Help create a world where a cure for CML is not just a hope but a reality. Give now: ride-for-a-cure.raiselysite.com/
CML Highlights of ASH 2023 - Biological overview
Просмотров 1,5 тыс.7 месяцев назад
Expert: Professor Michael Deininger Versiti Blood Research Institute Milwaukee (USA) 00:00 Introduction 01:28 Abstract 1785: Loss of function of SETD2 tumor suppressor in chronic myeloid leukemia (CML) progenitors fosters genomic instability and enhances chronogenic potential (De Santi S et al.) 02:35 Abstract 3151: Multiomic single-cell analysis identifies Van Willebrand factor and TIM3 expres...
CML Highlights of ASH 2023 - Clinical overview
Просмотров 4567 месяцев назад
CML Highlights of ASH 2023 - Clinical overview
Interview Timothy Hughes and Jorge Cortes
Просмотров 1147 месяцев назад
Interview Timothy Hughes and Jorge Cortes
Challenging Scenario 7: 53yo male with atypical CML
Просмотров 517 месяцев назад
Challenging Scenario 7: 53yo male with atypical CML
Challenging Scenario 5: 29yo male lost to treatment and returns in blast crisis. SCT not available
Просмотров 247 месяцев назад
Challenging Scenario 5: 29yo male lost to treatment and returns in blast crisis. SCT not available
Challenging Scenario 6: 37yo female with poor compliance, multiple TKI failure, taken to transplant
Просмотров 377 месяцев назад
Challenging Scenario 6: 37yo female with poor compliance, multiple TKI failure, taken to transplant
Challenging Scenario 4: Managing lack of compliance and loss of response
Просмотров 187 месяцев назад
Challenging Scenario 4: Managing lack of compliance and loss of response
Challenging Scenario 3: 47yo male with drug-related toxicities including thrombocytopenia
Просмотров 297 месяцев назад
Challenging Scenario 3: 47yo male with drug-related toxicities including thrombocytopenia
Challenging Scenario 2: 69yo male with TKI resistance and intolerance
Просмотров 377 месяцев назад
Challenging Scenario 2: 69yo male with TKI resistance and intolerance
Challenging Scenario 1: 24yo male in blast crisis at presentation
Просмотров 697 месяцев назад
Challenging Scenario 1: 24yo male in blast crisis at presentation
Key Issues in Treating Children & Young People with CML
Просмотров 738 месяцев назад
Key Issues in Treating Children & Young People with CML
The Impact of CML on Pregnancy & Fertility
Просмотров 608 месяцев назад
The Impact of CML on Pregnancy & Fertility
iCMLf Conversation: Highlights of 25th John Goldman Conference - Biological Overview & Q&A Session
Просмотров 699 месяцев назад
iCMLf Conversation: Highlights of 25th John Goldman Conference - Biological Overview & Q&A Session
iCMLf Conversations: Highlights of the 25th John Goldman Conference - Clinical Overview
Просмотров 689 месяцев назад
iCMLf Conversations: Highlights of the 25th John Goldman Conference - Clinical Overview
2023 Goldman Prize Keynote: From IRIS to SPIRIT toward treatment discontinuation for CML patients
Просмотров 9410 месяцев назад
2023 Goldman Prize Keynote: From IRIS to SPIRIT toward treatment discontinuation for CML patients
Where can I download the presentation files from the video?
sir good morning can i join in your foundation. im a cml diagnosed last dec. 2023 from phil..im now maintaining medicine imatinib 400mg per day
Hello doctor In your conclusion you dont mention the difference of e13 vs e14 transcript and also the influence of age. Is there a reason ?
Promo-SM 😇
Sir l want to be a oncholgy doctor. My sister is a cancer patient. now l am studying in Navodaya vidyalaya